Myriad Genetics reported $27.2M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Accelerate Diagnostics AXDX:US 13.65M 26.24M
Agilent A:US $ 1186M 73M
Becton, Dickinson and BDX:US $ 3147M 1244M
Bio Rad Laboratories BIO:US $ 802.32M 331.53M
Bruker BRKR:US $ 816.1M 252.1M
Danaher DHR:US $ 3717M 1131M
Exact Sciences EXAS:US $ 189.78M 125.7M
Fluidigm FLDM:US $ 29.98M 1.53M
Hologic HOLX:US $ 2290.8M 870M
Illumina ILMN:US $ 1351M 119M
Johnson & Johnson JNJ:US $ 1579M 322M
Mettler Toledo International MTD:US 116.95M 18.38M
Myriad Genetics MYGN:US $ 27.2M 231.2M
Nanostring Technologies NSTG:US $ 98.46M 8.61M
Orasure Technologies OSUR:US $ 70.72M 46.04M
Pacific Biosciences Of California PACB:US $ 428.57M 32.15M
Perkinelmer PKI:US $ 669.76M 51.44M
Quest Diagnostics DGX:US $ 712M 160M
Quidel QDEL:US $ 1275.54M 472.78M
Repligen RGEN:US $ 584.64M 19.17M
Thermo Fisher Scientific TMO:US $ 2752M 1725M
Veracyte VCYT:US $ 163.62M 9.58M
Waters WAT:US $ 480.07M 21.16M